Androgen deprivation therapy exacerbates Alzheimer's-associated cognitive decline via increased brain immune cell infiltration
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Androgen deprivation therapy (ADT) for prostate cancer increases dementia risk by causing brain inflammation. Natalizumab drug may reduce this cognitive decline by targeting immune cells.
Area Of Science
- Neuroscience
- Immunology
- Oncology
Background
- Androgen deprivation therapy (ADT) for prostate cancer is linked to higher dementia risk, including Alzheimer's disease (AD).
- The exact mechanisms connecting ADT to cognitive impairment in prostate cancer patients are not fully understood.
- Existing research often focuses on amyloid pathology, potentially overlooking other contributing factors.
Purpose Of The Study
- To investigate the mechanistic link between ADT and cognitive deficits in a prostate cancer mouse model.
- To explore the role of immune and inflammatory responses in ADT-induced neurodegeneration.
- To evaluate the therapeutic potential of natalizumab in mitigating ADT-related cognitive impairment.
Main Methods
- Development of a clinically relevant mouse model of prostate cancer with ADT.
- Analysis of immune and inflammatory changes in peripheral blood and brain tissue.
- Assessment of blood-brain barrier (BBB) integrity and immune cell infiltration.
- Evaluation of cognitive function and neuroinflammation markers.
- Testing the efficacy of natalizumab treatment.
Main Results
- ADT and prostate tumors induced significant immune and inflammatory alterations.
- ADT disrupted BBB integrity, leading to increased immune cell infiltration and neuroinflammation.
- Neuroinflammation and gliosis were enhanced, independent of amyloid plaque load.
- Natalizumab treatment reduced neuroinflammation and improved cognitive function in the model.
Conclusions
- ADT exacerbates cognitive deficits through an inflammatory mechanism distinct from amyloid pathology.
- Immune cell infiltration into the brain plays a critical role in ADT-induced neuroinflammation.
- Natalizumab shows promise as a therapeutic agent to counteract ADT's negative effects on cognition.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...